The first full year of the post-COVID-pandemic era was characterized in the United States by continued economic recovery, persistently high ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million - Pfizer Inc. agreed to pay over $59,746,277 to ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

The deal, agreed to by Purdue Pharma, the Sackler family members who own the company ... this massive influx of funds will ...

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

Gibson called for more funds to be allocated for mobile units to care for drug users in the Bronx; Naloxone training for residents and caregivers; and an ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.

Officials in states and local governments claimed that the opioid crisis was exacerbated by Purdue Pharma’s OxyContin and ...

A settlement agreement with Purdue Pharma and members of the Sackler family, could bring in another $250 million to New York ...

The money could benefit the 14 syringe service programs across the five boroughs that offer harm reduction services.